DK3638680T3 - Heteroaromatiske forbindelser som vanininhibitorer - Google Patents
Heteroaromatiske forbindelser som vanininhibitorer Download PDFInfo
- Publication number
- DK3638680T3 DK3638680T3 DK18731766.4T DK18731766T DK3638680T3 DK 3638680 T3 DK3638680 T3 DK 3638680T3 DK 18731766 T DK18731766 T DK 18731766T DK 3638680 T3 DK3638680 T3 DK 3638680T3
- Authority
- DK
- Denmark
- Prior art keywords
- heteroaromatic compounds
- vanin
- inhibitors
- vanin inhibitors
- heteroaromatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762518106P | 2017-06-12 | 2017-06-12 | |
| PCT/EP2018/065140 WO2018228934A1 (en) | 2017-06-12 | 2018-06-08 | Heteroaromatic compounds as vanin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3638680T3 true DK3638680T3 (da) | 2022-09-05 |
Family
ID=62631060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18731766.4T DK3638680T3 (da) | 2017-06-12 | 2018-06-08 | Heteroaromatiske forbindelser som vanininhibitorer |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US10364255B2 (da) |
| EP (1) | EP3638680B1 (da) |
| JP (1) | JP6880243B2 (da) |
| KR (1) | KR102607934B1 (da) |
| CN (1) | CN110770242B (da) |
| AR (1) | AR112086A1 (da) |
| AU (1) | AU2018285131B2 (da) |
| BR (1) | BR112019021703A2 (da) |
| CA (1) | CA3066946A1 (da) |
| CL (1) | CL2019003515A1 (da) |
| CO (1) | CO2019013823A2 (da) |
| DK (1) | DK3638680T3 (da) |
| EA (1) | EA039223B1 (da) |
| ES (1) | ES2927021T3 (da) |
| HU (1) | HUE060597T2 (da) |
| IL (1) | IL271104B (da) |
| MA (1) | MA49374A (da) |
| MX (1) | MX2019014876A (da) |
| PE (1) | PE20200340A1 (da) |
| PH (1) | PH12019502693A1 (da) |
| PL (1) | PL3638680T3 (da) |
| TW (1) | TW201920196A (da) |
| WO (1) | WO2018228934A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2927021T3 (es) * | 2017-06-12 | 2022-11-02 | Boehringer Ingelheim Int | Compuestos heteroaromáticos como inhibidores de vanina |
| EP3837263A1 (en) | 2018-08-13 | 2021-06-23 | F. Hoffmann-La Roche AG | New heterocyclic compounds as monoacylglycerol lipase inhibitors |
| DK3844161T3 (da) * | 2018-08-28 | 2022-12-12 | Boehringer Ingelheim Int | Heteroaromatiske forbindelser som vanininhibitorer. |
| AR117229A1 (es) | 2018-12-03 | 2021-07-21 | Boehringer Ingelheim Int | Compuestos heteroaromáticos como inhibidores de vanina |
| EP4028403B1 (en) | 2019-09-12 | 2023-11-22 | F. Hoffmann-La Roche AG | 4,4a,5,7,8,8a-hexapyrido[4,3-b][1,4]oxazin-3-one compounds as magl inhibitors |
| US20230107927A1 (en) | 2020-02-28 | 2023-04-06 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004018811D1 (de) * | 2003-10-09 | 2009-02-12 | Abbott Lab | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
| EP3303303A1 (en) * | 2015-05-29 | 2018-04-11 | Pfizer Inc | Novel heterocyclic compounds as inhibitors of vanin-1 enzyme |
| AU2017296338A1 (en) * | 2016-07-14 | 2019-01-03 | Pfizer Inc. | Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme |
| ES2927021T3 (es) * | 2017-06-12 | 2022-11-02 | Boehringer Ingelheim Int | Compuestos heteroaromáticos como inhibidores de vanina |
-
2018
- 2018-06-08 ES ES18731766T patent/ES2927021T3/es active Active
- 2018-06-08 CA CA3066946A patent/CA3066946A1/en active Pending
- 2018-06-08 PL PL18731766.4T patent/PL3638680T3/pl unknown
- 2018-06-08 CN CN201880039562.3A patent/CN110770242B/zh active Active
- 2018-06-08 BR BR112019021703-7A patent/BR112019021703A2/pt unknown
- 2018-06-08 KR KR1020197038628A patent/KR102607934B1/ko active IP Right Grant
- 2018-06-08 MX MX2019014876A patent/MX2019014876A/es unknown
- 2018-06-08 JP JP2019566724A patent/JP6880243B2/ja active Active
- 2018-06-08 DK DK18731766.4T patent/DK3638680T3/da active
- 2018-06-08 HU HUE18731766A patent/HUE060597T2/hu unknown
- 2018-06-08 WO PCT/EP2018/065140 patent/WO2018228934A1/en unknown
- 2018-06-08 MA MA049374A patent/MA49374A/fr unknown
- 2018-06-08 AU AU2018285131A patent/AU2018285131B2/en active Active
- 2018-06-08 US US16/003,252 patent/US10364255B2/en active Active
- 2018-06-08 PE PE2019002531A patent/PE20200340A1/es unknown
- 2018-06-08 EA EA202090014A patent/EA039223B1/ru unknown
- 2018-06-08 EP EP18731766.4A patent/EP3638680B1/en active Active
- 2018-06-11 AR ARP180101573A patent/AR112086A1/es unknown
- 2018-06-11 TW TW107119946A patent/TW201920196A/zh unknown
-
2019
- 2019-05-13 US US16/410,037 patent/US20190263828A1/en not_active Abandoned
- 2019-11-28 PH PH12019502693A patent/PH12019502693A1/en unknown
- 2019-12-02 IL IL271104A patent/IL271104B/en unknown
- 2019-12-02 CL CL2019003515A patent/CL2019003515A1/es unknown
- 2019-12-09 CO CONC2019/0013823A patent/CO2019013823A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3638680A1 (en) | 2020-04-22 |
| MX2019014876A (es) | 2020-02-13 |
| US10364255B2 (en) | 2019-07-30 |
| PE20200340A1 (es) | 2020-02-14 |
| CA3066946A1 (en) | 2018-12-20 |
| IL271104B (en) | 2022-03-01 |
| CN110770242A (zh) | 2020-02-07 |
| CN110770242B (zh) | 2022-08-19 |
| PL3638680T3 (pl) | 2022-12-19 |
| AU2018285131B2 (en) | 2021-11-11 |
| WO2018228934A1 (en) | 2018-12-20 |
| AR112086A1 (es) | 2019-09-18 |
| KR102607934B1 (ko) | 2023-12-01 |
| EA039223B1 (ru) | 2021-12-20 |
| BR112019021703A2 (pt) | 2020-05-12 |
| CL2019003515A1 (es) | 2020-06-19 |
| TW201920196A (zh) | 2019-06-01 |
| PH12019502693A1 (en) | 2020-07-13 |
| AU2018285131A1 (en) | 2019-10-31 |
| US20190263828A1 (en) | 2019-08-29 |
| MA49374A (fr) | 2021-04-21 |
| EP3638680B1 (en) | 2022-08-10 |
| ES2927021T3 (es) | 2022-11-02 |
| EA202090014A1 (ru) | 2020-05-12 |
| CO2019013823A2 (es) | 2020-01-17 |
| HUE060597T2 (hu) | 2023-04-28 |
| US20180354968A1 (en) | 2018-12-13 |
| JP2020522517A (ja) | 2020-07-30 |
| JP6880243B2 (ja) | 2021-06-02 |
| IL271104A (en) | 2020-01-30 |
| KR20200013718A (ko) | 2020-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3697785T3 (da) | Imidazo-pyridine forbindelser som pad-inhibitorer | |
| DK3656769T3 (da) | Aryl-phosphor-oxygen-forbindelse som egfr-kinase-inhibitor | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3277677T3 (da) | 1-cyano-pyrrolidinforbindelser som usp30-hæmmere | |
| DK3394033T3 (da) | Heterocykliske forbindelser som immunmodulatorer | |
| DK3728252T3 (da) | 4-azaindolforbindelser | |
| DK3298002T3 (da) | Heterocykliske amider som kinasehæmmere | |
| DK3390395T3 (da) | Forbindelser, der kan anvendes som kinase-inhibitorer | |
| DK3324977T3 (da) | Benzodiazepinderivater som rsv-inhibitorer | |
| DK3341367T3 (da) | Bicyklisk-fusionerede heteroaryl- eller arylforbindelser som irak4-modulatorer | |
| DK3303348T3 (da) | Naphthyridinforbindelser som JAK-kinaseinhibitorer | |
| DK3582780T3 (da) | Aminopyrimidinforbindelser, der er anvendelige som SSAO-inhibitorer | |
| DK3294713T5 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
| DK3609898T3 (da) | Forbindelser, der er nyttige som ret-hæmmere | |
| DK3533796T3 (da) | Aminopyrazolopyrimidinforbindelse anvendt som neutrof faktor tyrosinkinasereceptor inhibitor | |
| DK3638680T3 (da) | Heteroaromatiske forbindelser som vanininhibitorer | |
| DK3544981T3 (da) | Benzodiazoliumforbindelser som enac-inhibitorer | |
| DK3458460T3 (da) | Imidazoler som histondemethylase-inhibitorer | |
| DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
| DK3612519T3 (da) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser | |
| DK3592745T3 (da) | Pyrimidopyrimidinoner anvendelige som Wee-1 kinaseinhibitorer | |
| DK3681885T3 (da) | Tetrahydro-imidazo-quinolinsammensætninger som cbp/p300-inhibitorer | |
| DK3552017T3 (da) | Forbindelser, der er anvendelige som ripk1-inhibitorer | |
| IL283397A (en) | Heteroaromatic compounds as vanin inhibitors |